Strategic communicator with more than 25 years of experience in the life-science industry, covering investor relations, communication, business strategy and healthcare investment

Mary-Ann Is an experienced investor relations and communications advisor specializing in life sciences. With a track record in developing and executing high impact investor relations and communication programs, she has supported five companies through NASDAQ listings, as well as multiple financings exceeding $800 million in aggregate. Former Global Head of Healthcare for HSBC Asset Management. Previous leadership roles in market research and business strategy at digital health pioneers, Epocrates and ConnectiveRx